BRAINLIFE Brain Tumor Medical Database
Glioblastoma / Treatment
Troglitazone
Home > Database > Glioblastoma > Treatment > Troglitazone

Contents

Page Bottom



Overviews

Page TopPage Bottom



Laboratory Investigations

Page TopPage Bottom


Yasuharu Akasaki, Gentao Liu, Harry H. Matundan, Hiushan Ng, Xiangpeng Yuan, Zhaohui Zeng, Keith L. Black, and John S. Yu 
A peroxisome proliferator-activated receptor-γ (PPARγ) agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein tyrosine phosphatase-1B on human glioma cells
J. Biol. Chem., Vol. 281, Issue 10, 6165-6174, March 10, 2006; Publ. online ahead of print Nov. 30, 2005; DOI: 10.1074/jbc.M505266200
  Abstract |   Reprint | News


Clinical Investigations

Page TopPage Bottom



First-diagnosis Tumors

Page TopPage Bottom



Recurrent Tumors

Page TopPage Bottom



Elderly Patients

Page TopPage Bottom



Pediatric Patients

Page TopPage Bottom



Case Reports

Page TopPage Bottom



Complications

Page TopPage Bottom



Survival

Page TopPage Bottom


Page Top


This website is certified by Health On the Net Foundation. Click to verify. HOMEARCHIVES OF NEURO-ONCOLOGYCURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTS
SERVICES: About BrainLife | Brain Tumor Medical Database | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications

This site complies with the HONcode standard for trustworthy health information: verify here bottom